Drug Testing Locations - Fife Heights, WA

Drug Testing in Fife Heights, WA

Fife Heights, Washington Statistics

In Fife Heights, Pierce County, 15% of high school students reported using marijuana in the past month.

Fife Heights, WA, saw a 20% increase in opioid-related hospitalizations over the past two years, according to Pierce County data.

Pierce County's Fife Heights area reported over 300 cases of drug-related crimes in the past year.

In 2022, fentanyl was involved in nearly 60% of all overdose deaths in Fife Heights, Pierce County.

Pierce County statistics indicate that treatment admissions for methamphetamine use from Fife Heights increased by 25% in the last year.

Pierce County, including Fife Heights, had an estimated 8% of its population reporting substance use disorder in a recent survey.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Fife Heights, WA & Drug Testing Policies

Employers in Fife Heights, WA, have implemented strict drug testing policies to maintain a safe workplace environment. Many companies conduct pre-employment, random, and post-incident drug tests to deter substance abuse among employees. For guidelines, refer to the U.S. Department of Labor.

Some employers also offer employee assistance programs (EAPs) to support workers who may be struggling with drug addiction. These programs often include counseling services, rehabilitation referrals, and education on substance abuse prevention. Learn more at the Substance Abuse and Mental Health Services Administration.

Government Efforts with Drug Problems in Fife Heights, WA

The government in Fife Heights, WA, is actively working to combat drug problems through initiatives focused on public awareness and prevention. Local authorities collaborate with state programs to provide educational resources and health services for affected citizens. Washington State Department of Social and Health Services offers various support systems.

Efforts include partnerships between local law enforcement and public health agencies to create comprehensive strategies addressing drug abuse. Community engagement programs aim to reduce stigma and increase access to treatment facilities. Resources can be found at Pierce County's official website.

Local Drug Busts & News in Fife Heights, WA

Fife Heights, WA, has been the site of several significant drug busts over the past year. Local law enforcement, in collaboration with federal agencies, dismantled a major drug trafficking ring responsible for distributing methamphetamine across Pierce County.

Community awareness events, such as drug take-back programs, have been organized to educate residents about safe disposal of unused prescriptions. These events aim to prevent the misuse of prescription drugs and reduce local drug abuse rates.

Additionally, workshops and seminars are held regularly in Fife Heights to provide education on recognizing the signs of drug abuse, ways to intervene, and available treatment options for substance use disorders.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Fife Heights, WA. Trusted by employers nationwide for accurate results and exceptional service.

Washington DOT/Non DOT Physicals

Washington Vision Tests

Washington Audiograms

Washington Respirator Fit Tests

Washington Lift Tests

Washington Background Checks

Clinical Testing Services

TB Testing in WA

Diabetes Testing in WA

Infectious Disease Testing in WA

Sickle Cell Anemia Testing in WA

Women/Men's Health Testing in WA

Resources & Citations

Crisis Clinic of Pierce County

PCO Hope

DRUGINFree

Nar-Anon Family Groups

Al-Anon Family Groups

Sea Mar Community Health Centers

Washington State Association of Drug Court Professionals

Pierce College Counseling Center

Recovery Cafe

Multicultural Addictions Network of WA

Drug Testing Near Fife Heights, WA

Dash Point, WA

Puyallup, WA

Lakeland North, WA

Dieringer, WA

Browns Point, WA

Tacoma, WA

Federal Way, WA

North Puyallup, WA

Waller, WA

Lakeland South, WA

Edgewood, WA

Fife, WA

Milton, WA

Frequently Asked Questions

Customer Reviews